SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 77 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $223,000 | -53.9% | 292,650 | +4.0% | 0.00% | -100.0% |
Q3 2016 | $484,000 | -4.7% | 281,494 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $508,000 | +1932.0% | 282,158 | +2517.2% | 0.00% | – |
Q1 2016 | $25,000 | 0.0% | 10,781 | 0.0% | 0.00% | – |
Q4 2015 | $25,000 | 0.0% | 10,781 | -1.4% | 0.00% | – |
Q3 2015 | $25,000 | 0.0% | 10,929 | +26.6% | 0.00% | – |
Q2 2015 | $25,000 | +19.0% | 8,632 | -9.6% | 0.00% | – |
Q1 2015 | $21,000 | +50.0% | 9,545 | 0.0% | 0.00% | – |
Q4 2014 | $14,000 | 0.0% | 9,545 | +23.6% | 0.00% | – |
Q3 2014 | $14,000 | +7.7% | 7,723 | +2.6% | 0.00% | – |
Q2 2014 | $13,000 | – | 7,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |